Oxidative nerve cell death in Alzheimer's disease and stroke: Antioxidants as neuroprotective compounds

Biological Chemistry

Volumn 383, Issue 3-4, 2002, Pages 521-536

  Behl, Christian ^a   Moosmann, Bernd ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Alzheimer's disease; Antioxidant; Estrogen; Imine; Neuroprotection; Oxidative stress; Phenol; Stroke

Indexed keywords

ALPHA TOCOPHEROL; AMINO ACID; AMYLOID; ANTIOXIDANT; ASCORBIC ACID; CANNABIDIOL; CANNABINOL; CYTOKINE; EPICATECHIN; ESTRADIOL; FLAVONOID; HYDROQUINONE DERIVATIVE; IMINE; NEUROTOXIN; PEPTIDE DERIVATIVE; PHENOL DERIVATIVE; PHENOTHIAZINE; PHENOXAZINE DERIVATIVE; POLYPHENOL DERIVATIVE; QUERCETIN; REACTIVE OXYGEN METABOLITE; SCAVENGER; SEROTONIN; STILBENE DERIVATIVE; TETRAHYDROCANNABINOL; TROLOX C; TRYPTOPHAN DERIVATIVE; TYROSINE DERIVATIVE; UNINDEXED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; APOPTOSIS; BRAIN ISCHEMIA; CELL DEATH; CELL DESTRUCTION; CELL LOSS; CELL PROTECTION; CHRONIC DISEASE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE COURSE; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG PENETRATION; DRUG STRUCTURE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NERVE CELL; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; STROKE; STRUCTURE ACTIVITY RELATION;

ALZHEIMER DISEASE; ANIMALS; ANTIOXIDANTS; CELL DEATH; CEREBROVASCULAR ACCIDENT; HUMANS; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS;

ANIMALIA; LETHRINIDAE;

EID: 0036254698     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2002.053     Document Type: Review

References (130)

1. Nonantioxidant functions of α-tocopherol in smooth muscle cells
2. Aging energy, and oxidative stress in neurodegenerative disorders
3. The free radical theory of aging matures
4. Alzheimer's disease and oxidative stress: Implications for novel therapeutic approaches
5. Apoptosis and Alzheimer's disease
6. Estrogen - Mystery drug for the brain? The neuroprotective activities of the female sex hormone
7. The female sex hormone oestrogen as a neuroprotectant
8. Vitamin E protects nerve cells from amyloid β protein toxicity
9. Hydrogen peroxide mediates amyloid β protein toxicity
10. 17-β Estradiol protects neurons from oxidative stress-induced cell death in vitro
11. Neuroprotection against oxidative stress by estrogens: Structure-activity relationship
12. Comparison of the antioxidant effects of equine estrogens, red wine components, vitamin E, and probucol on low-density lipoprotein oxidation in post-menopausal women
13. Scavestrogens protect IMR 32 cells from oxidative stress-induced cell death
14. Polyphenols: Chemistry, dietary sources, metabolism, and nutritional significance
15. Apoptosis: Overview and signal transduction pathways
16. β-Amyloid toxicity in organotypic hippocampal cultures: Protection by EUK-8, a synthetic catalytic free radical scavenger
17. Oxygen radicals in focal cerebral ischemia
18. Reactive oxygen radicals in signaling and damage in the ischemic brain
19. Treatment with a copper-zinc chelator markedly and rapidly inhibits β-amyloid accumulation in Alzheimer's disease transgenic mice
20. Oxidative stress and Alzheimer disease
21. Dopaminergic cell death induced by MPP(+), oxidant and specific neurotoxicants shares the common molecular mechanism
22. Efficacy of antioxidant therapies in transient focal ischemia in mice
23. Oxidative stress, glutamate, and neurodegenerative disorders
24. Intramuscular desferrioxamine in patients with Alzheimer's disease
25. Antioxidant therapy: A new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury
26. Clinical trials with neuroprotective drugs in acute ischaemic stroke: Are we doing the right thing?
27. Pathobiology of ischaemic stroke: An integrated view
28. Estradiol protects against ischemic injury
29. β-Amyloid protein aggregation: Its implication in the physiopathology of Alzheimer's disease
30. Prospects for pharmacological intervention in Alzheimer disease
31. Oxidants, oxidative stress and the biology of ageing
32. The cytosolic antioxidant copper/zinc-superoxide dismutase prevents the early release of mitochondrial cytochrome c in ischemic brain after transient focal cerebral ischemia in mice
33. Oxidative stress-induced neurodegenerative diseases: The need for antioxidants that penetrate the blood-brain barrier
34. Mitochondria and apoptosis
35. Neuroprotective effects of estrogens: Potential mechanisms of action
36. 17α-Estradiol exerts neuroprotective effects on SK-N-SH cells
37. Vitamin E and Alzheimer disease: The basis for additional clinical trials
38. Sustained efficacy and safety of idebenone in the treatment of Alzheimer's disease: Update on a 2-year double-blind multicentre study
39. Proteolysis by presenilins and the renaissance of tau
40. Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study
41. Central nervous system trauma and stroke. II. Physiological and pharmacological evidence for involvement of oxygen radicals and lipid peroxidation
42. Antioxidants in human health and disease
43. Role of free radicals in the neurodegenerative diseases - Therapeutic implications for antioxidant treatment
44. 9-tetrahydrocannabinol are neuroprotective antioxidants
45. Aging: Phenomena and theories
46. Observation of metastable Aβ amyloid protofibrils by atomic force microscopy
47. Direct evidence of oxidative injury produced by the Alzheimer's β-amyloid peptide (1-40) in cultured hippocampal neurons
48. Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons
49. Oestrogens and dementia
50. Estrogen replacement therapy in older women
51. Dehydroascorbic acid, a blood-brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental stroke
52. Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms
53. Identification of proteins containing cysteine residues that are sensitive to oxidation by hydrogen peroxide at neutral pH
54. Targeting small Aβ oligomers: The solution to an Alzheimer's disease conundrum?
55. George E. Brown memorial lecture. Oxygen radicals in cerebral vascular injury
56. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β
57. Neuroprotective effects of a novel nitrone, NXY-059, after transient focal cerebral ischemia in the rat
58. Diffusible, nonfibrillar ligands derived from Aβ(1-42) are potent central nervous system neurotoxins
59. A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion
60. β-Amyloid toxicity does not require RAGE protein
61. Oxidative stress in brain ischemia
62. Signaling by reactive oxygen species in the nervous system
63. The role of oxidative stress in Alzheimer disease
64. Neuroprotective properties of cannabinoids against oxidative stress: Role of the cannabinoid receptor CB1
65. Alzheimer's disease
66. Cellular actions of β-amyloid precursor protein and its soluble and fibrillogenic derivatives
67. Neurodegenerative disorders and ischemic brain diseases
68. A radical approach to stroke therapy
69. Estrogen actions in the central nervous system
70. Alzheimer disease and neuroinflammation
71. The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties
72. Cytoprotective antioxidant function of tyrosine and tryptophan residues in transmembrane proteins
73. Secretory peptide hormones are biochemical antioxidants: Structure-activity relationship
74. Neuroprotective potential of aromatic alcohols against oxidative cell death
75. Protective activity of aromatic amines and imines against oxidative nerve cell death
76. The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I)
77. Molecular diversity of glutamate receptors and implication for brain function
78. Intravenous administration of MEK inhibitor U0126 affords brain protection against forebrain ischemia and focal cerebral ischemia
79. Inhibition of oxidation of low-density lipoprotein by a novel antioxidant, BO-653, prepared by theoretical design
80. Phenolic antioxidants: A rationale for design and evaluation of novel antioxidant drug for atherosclerosis
81. S-allylcysteine inhibits free radical production, lipid peroxidation and neuronal damage in rat brain ischemia
82. Neuronal oxidative stress precedes amyloid β deposition in Down syndrome
83. Oxidative damage is the earliest event in Alzheimer's disease
84. Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection
85. 2+-loaded brain neurons
86. Effects of the spin trap α-phenyl-N-tert-butyl nitrone (PBN) in transient forebrain ischaemia in the rat
87. Blood-brain barrier transport and brain sequestration of steroid hormones
88. Ebselen: Prospective therapy for cerebral ischaemia
89. Multiple antioxidants in the prevention and treatment of Alzheimer disease: Analysis of biologic rationale
90. Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis
91. Apoptosis-regulating proteins as targets for drug discovery
92. Functional pleiotropy of the neurohormone melatonin: Antioxidant protection and neuroendocrine regulation
93. Flavonoid antioxidants
94. Vitamin E: Protective role of a Janus molecule
95. Complement activation by β-amyloid in Alzheimer disease
96. Induction of reactive oxygen species in neurons by haloperidol
97. A controlled trial of selegiline, α-tocopherol, or both as treatment for Alzheimer's disease
98. Flavonoids protect neurons from oxidized low-density-lipoprotein-induced apoptosis involving c-Jun N-terminal kinase (JNK), c-Jun and caspase-3
99. Oxidative glutamate toxicity can be a component of the excitotoxicity cascade
100. Alzheimer's disease: Genes, proteins, and therapy
101. Molecular basis of vitamin E action - Tocotrienol potently inhibits glutamate-induced pp60(c-Src) kinase activation and death of HT4 neuronal cells
102. Can estrogen keep you smart? Evidence from clinical studies
103. Biochemistry of oxidative stress
104. Strategies of antioxidant defence
105. Oxidative stress in neurodegenerative diseases
106. Widespread peroxynitrite-mediated damage in Alzheimer's disease
107. Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures
108. Involvement of the 5-lipoxygenase pathway in the neurotoxicity of the prion peptide PrP106-126
109. Copper in disorders with neurological symptoms: Alzheimer's Menkes, and Wilson diseases
110. A 1-year controlled trial of acetyl-L-carnitine in early-onset AD
111. Tirilazad mesylate in acute ischemic stroke: A systematic review
112. β-Amyloid-induced neuronal apoptosis requires c-Jun N-terminal kinase activation
113. A quantum mechanical explanation of the antioxidant activity of flavonoids
114. α-Tocopherol in CSF of subjects taking high-dose vitamin E in the Datatop study
115. Amyloid beta-protein fibrillogenesis-detection of a protofibrillar intermediate
116. Amyloid β-protein fibrillogenesis - Structure and biological activity of protofibrillar intermediates
117. Estrogen provides neuroprotection in transient forebrain ischemia through perfusion-independent mechanisms in rats
118. Protein aggregation and pathogenesis of Huntington's disease: Mechanisms and correlations
119. A controlled study of 2 doses of idebenone in the treatment of Alzheimer's disease
120. Mechanisms of neurodegenerative disorders, part 2: Control of cell death
121. Tirilazad reduces cortical infarction after transient but not permanent focal cerebral ischemia in rats
122. Protective effects of idebenone and α-tocopherol on β-amyloid-(1-42)-induced learning and memory deficits in rats: Implication of oxidative stress in β-amyloid-induced neurotoxicity in vivo
123. Rage and amyloid-β peptide neurotoxicity in Alzheimer's disease
124. Neuroprotection by 2-h postischemia administration of two free radical scavengers, α-phenyl-N-tert-butyl-nitrone (PBN) and N-tert-butyl-(2-sulfophenyl)-nitrone (S-PBN), in rats subjected to focal embolic cerebral ischemia
125. Mechanisms of neuronal degeneration in Alzheimer's disease
126. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease
127. Dietary flavonoids as potential neuroprotectants
128. Phenothiazines as lipid peroxidation inhibitors and cytoprotective agents
129. Apoptosis in the nervous system